A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain ...
Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation (“Insulet” or the “Company”) ...
PODD's Omnipod 5 momentum and global growth support its outlook, but competitive pressure and macro costs may test its margin ...
Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the commercial launch of its ...
The Omnipod 5 with an iPhone [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 insulin pump and Omnipod Discover platform in Spain. With the launch, ...
Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation ("Insulet" or the "Company") and certain officers. The class action, filed in the United States District ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results